论文部分内容阅读
Background: We have demonstrated previously that spleen-derived dendritic cells (DCs) modified with atorvastatin can suppress immune response in experimental autoimmune myasthenia gravis (EAMG).The therapeutic effects are mediated by exogenous DCs that can migrate to immune organs and decrease the expression of CD86 and MHC class Ⅱ on endogenous DCs, which could further induce T cell anergy and immune tolerance in EAMG rats.Increasing evidences from animal experiments and clinical studies have shown that exosomes (EXOs) have involved in the immune regulation.In particular, EXOs derived from DCs can carry regulatory molecules and target to their corresponding acceptor cells.